Started by renowned orthopaedic surgeon Dr Vikram Shah, Shalby is a multi-specialty hospitals chain with expertise in joint replacement.
DLF has a strong growth story given its robust launch pipeline. Buy for target price of ₹1081 (30% upside): Nuvama
We remain upbeat on DLFU’s growth prospects on strong sectoral tailwinds (industry-wide consolidation, record low inventory in its home market, and greater preference for branded luxury inventory), an extensive launch pipeline, and expansion in its annuity portfolio. A strong Balance Sheet, with consistent cash flow, lends comfort. We revise our TP to INR1,081 (INR1,087 earlier). Maintain ‘BUY’.
IPO: Swiggy is well recognized as a leader and a pioneer in hyperlocal commerce innovation. Subscribe to the IPO: SBI Securities
Swiggy Ltd (Swiggy) is a new-age technology company offering users an easyto-use convenience platform accessible through a unified app to browse, select, order & pay for food, grocery & household items (Instamart) and have their orders delivered to their doorstep through on-demand delivery partner network (Genie)
Arvind Smartspaces is positioned at a transformative point, from which exponential growth is expected. Buy for target price of 1085 (40% upside): Axis Securities
The company is confident in achieving its guidance of 30-35% growth in pre-sales. With a total inventory of approximately Rs 10,000 Cr (ongoing, upcoming, and BD), it is positioned at a transformative point, from which exponential growth is expected. The company is prepared to expand across different geographies and is inclined to undertake more vertical projects in the future. Its balance sheet strength supports a substantial increase in BD while maintaining growth momentum.
Archean Chemical Industries Ltd has Twin Tailwind from Dual Expansion. Buy for target price of ₹943 (58% upside): KR Choksey
We firmly believe ACI is on the right track to expand into more critical, value-added products. On one hand, the expansion into bromine derivatives, and on the other side, the recent strategic investments into semiconductor and energy storage system, highlight the company’s intent to move deeper into the value chain and gradually transition away from commodity-type business. We reiterate our “BUY” rating on the stock, valuing it at a P/E multiple of 19x on FY26 EPS, with a target price of 943
Buy the Fear as the Market has reached “Value Zone”. 10 stocks recommended for up to 37% upside potential by Rahul Sharma of JMFICS
Rahul Sharma of JMFICS says the market (Nifty at 24000) is oversold & has reached “value zone” which means one can expect maximum upside opportunity. It is time to buy the fear. Large Caps are exhibiting highly favourable risk reward at current levels and can do well inspite of challenges. He has recommended 10 stocks for 18% to 37% upside potential
Recent Comments